Skip to main content
. Author manuscript; available in PMC: 2016 Sep 25.
Published in final edited form as: Biochem Biophys Res Commun. 2015 Aug 15;465(3):534–541. doi: 10.1016/j.bbrc.2015.08.055

Table 1.

Inhibition of lipid accumulation and apoptosis by antipsychotics and orlistat. No compound (black); 50μM (gray); and 100μM (white) compound. Refer to Fig. 3A and 3B for Grassofermata data. Levels not connected by the same letter are significantly different at p<0.05.

Name of compound (Type of compound/ Chemical class1) Lipid Accumulation DAPI staining
Clozapine (Atypical/ Dibenzodiazepines)
graphic file with name nihms717791t1.jpg 		graphic file with name nihms717791t2.jpg graphic file with name nihms717791t3.jpg
Quetiapine (Atypical/ Dibenzodiazepines)
graphic file with name nihms717791t4.jpg 		graphic file with name nihms717791t5.jpg graphic file with name nihms717791t6.jpg
Olanzapine (Atypical/ Thienobenzodiazepines)
graphic file with name nihms717791t7.jpg 		graphic file with name nihms717791t8.jpg graphic file with name nihms717791t9.jpg
Risperidone (Atypical/ Benzisoxazoles)
graphic file with name nihms717791t10.jpg 		graphic file with name nihms717791t11.jpg graphic file with name nihms717791t12.jpg
Haloperidol (Typical/ Butyrophenones)
graphic file with name nihms717791t13.jpg 		graphic file with name nihms717791t14.jpg graphic file with name nihms717791t15.jpg
Orlistat (Pancreatic lipase inhibitor)
graphic file with name nihms717791t16.jpg 		graphic file with name nihms717791t17.jpg graphic file with name nihms717791t18.jpg